NO873860L - Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling. - Google Patents

Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.

Info

Publication number
NO873860L
NO873860L NO873860A NO873860A NO873860L NO 873860 L NO873860 L NO 873860L NO 873860 A NO873860 A NO 873860A NO 873860 A NO873860 A NO 873860A NO 873860 L NO873860 L NO 873860L
Authority
NO
Norway
Prior art keywords
ifosfamide
weight
solution
hexite
parts
Prior art date
Application number
NO873860A
Other languages
English (en)
Norwegian (no)
Other versions
NO873860D0 (no
Inventor
Dieter Sauerbier
Uwe-Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of NO873860D0 publication Critical patent/NO873860D0/no
Publication of NO873860L publication Critical patent/NO873860L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Amplifiers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO873860A 1986-10-31 1987-09-15 Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling. NO873860L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (2)

Publication Number Publication Date
NO873860D0 NO873860D0 (no) 1987-09-15
NO873860L true NO873860L (no) 1988-05-02

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873860A NO873860L (no) 1986-10-31 1987-09-15 Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.

Country Status (25)

Country Link
EP (1) EP0265812B1 (enExample)
JP (1) JPS63159319A (enExample)
KR (1) KR900003491B1 (enExample)
AT (1) ATE55250T1 (enExample)
AU (1) AU598602B2 (enExample)
CA (1) CA1314231C (enExample)
DD (1) DD262582A5 (enExample)
DE (1) DE3764235D1 (enExample)
DK (1) DK169308B1 (enExample)
EG (1) EG18333A (enExample)
ES (1) ES2017982B3 (enExample)
FI (1) FI87140C (enExample)
GE (1) GEP19971025B (enExample)
GR (1) GR3000708T3 (enExample)
HU (1) HU197987B (enExample)
IL (1) IL84312A (enExample)
IN (1) IN168119B (enExample)
LV (1) LV10051B (enExample)
MX (1) MX8958A (enExample)
NO (1) NO873860L (enExample)
PT (1) PT86032B (enExample)
RU (1) RU1836079C (enExample)
UA (1) UA11075A (enExample)
YU (1) YU197387A (enExample)
ZA (1) ZA878183B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
DE69928500T2 (de) * 1998-03-03 2006-08-03 Eli Lilly And Co., Indianapolis Pharmazeutische zusammensetzung enthaltend den phospholipase inhibitor natrium-[[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1 h-indol-4-yl]oxy]acetat
CA2497898C (en) * 2002-09-05 2012-02-07 Bharat Serums & Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
CN100463678C (zh) * 2002-12-02 2009-02-25 印度血清及疫苗有限公司 用于肠胃外给药的异环磷酰胺组合物及其制备方法
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
BRPI0715279A2 (pt) * 2006-09-29 2013-06-11 Infa Sa sistema de embalagem, sistema de embalagem para uma composiÇço farmacÊutica, mÉtodo para transferir uma composiÇço farmcÊutica para administraÇço por infusço intravenosa, uso de um sistema de embalagem, kit para administraÇço parenteral de fÁrmacos com um acesso intravenoso e kit admnistraÇço parenteral de princÍpios ativos
CN105900385B (zh) * 2014-12-04 2019-08-27 华为技术有限公司 在数据通信网中的负载分配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
DE3764235D1 (de) 1990-09-13
LV10051A (lv) 1994-05-10
IN168119B (enExample) 1991-02-09
AU598602B2 (en) 1990-06-28
IL84312A (en) 1991-11-21
EP0265812B1 (de) 1990-08-08
DK569687D0 (da) 1987-10-30
IL84312A0 (en) 1988-03-31
PT86032A (de) 1987-11-01
EG18333A (en) 1993-12-30
UA11075A (uk) 1996-12-25
DK169308B1 (da) 1994-10-10
LV10051B (en) 1995-06-20
NO873860D0 (no) 1987-09-15
HUT44932A (en) 1988-05-30
RU1836079C (ru) 1993-08-23
GEP19971025B (en) 1997-04-06
DK569687A (da) 1988-05-01
EP0265812A1 (de) 1988-05-04
CA1314231C (en) 1993-03-09
PT86032B (pt) 1990-08-31
DD262582A5 (de) 1988-12-07
ZA878183B (en) 1988-05-02
JPH0543684B2 (enExample) 1993-07-02
KR880004814A (ko) 1988-06-27
FI87140B (fi) 1992-08-31
HU197987B (en) 1989-07-28
GR3000708T3 (en) 1991-10-10
FI874727A0 (fi) 1987-10-27
ES2017982B3 (es) 1991-03-16
JPS63159319A (ja) 1988-07-02
YU197387A (en) 1988-12-31
FI87140C (fi) 1992-12-10
MX8958A (es) 1993-12-01
KR900003491B1 (ko) 1990-05-21
AU8052987A (en) 1988-05-05
ATE55250T1 (de) 1990-08-15
FI874727L (fi) 1988-05-01

Similar Documents

Publication Publication Date Title
US4959215A (en) Ifosfamide-mesna lyophilizate and process for its preparation
RU2106138C1 (ru) Усовершенствованные лиофилизированные и фосфамидные композиции
NO873860L (no) Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.
US5204335A (en) Ifosfamide lyophilisate and process for its preparation
AU757002B2 (en) Pharmaceutical compositions containing the phospholipase inhibitor sodium ((3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- phenylmethyl)-1H-indol-4-YL)oxy)acetate
FR2782455A1 (fr) Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine
KR20030074389A (ko) 동결건조된 단백질의 재구성 방법
DK175808B1 (da) Ifosfamid-mesna-lyofilisat og fremgangsmåde til fremstilling deraf
CN102123714A (zh) 莰佛胺制剂及其制备
EP3092009A1 (en) Lyophilized mesna compositions
US11707434B2 (en) Method for preparing organic solvent-free lyophilized cyclophosphamide
KR20180041814A (ko) 유기용매 유리 동결건조 시클로포스파미드의 제조방법
Czyż et al. Thermostability of Freeze-Dried Plant-Made VLP-Based
KR20240043740A (ko) 젤란검 조성물 및 이의 제조 방법
CZ20003208A3 (cs) Farmaceutické přípravky obsahující inhibitor fosfolipázy [[3-(2-amino-l,2-dioxoethyl)-2-ethyll-(fenylmethyl)-lH-indol-4-yl]oxy]acetát sodný